NCT05561621View on ClinicalTrials.gov

Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
Multiple Sclerosis
Interventions
OTHER

Voice analysis

Voice analysis

Trial Locations (1)

3010

Inselspital University Hospital Bern, Bern

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Audeering GMBH

INDUSTRY

collaborator

Biogen

INDUSTRY

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT05561621 - Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers | Biotech Hunter | Biotech Hunter